Inclusion criteria consisted of adult patients who were evaluated in the emergency department for stroke and received either thrombolysis (tissue plasminogen activator (tPA) or TNK) or procedural neurointervention between March 2018 and May 2020. This evidence concerns the gene PLAT and stroke disorder.